Protective effect of oral L-arginine supplementation on cyclosporine induced nephropathy in rats.

作者: Meltem Kuruş , Mukaddes Eşrefoğlu , Aysun Bay , Feral Öztürk

DOI: 10.1007/S11255-004-0011-5

关键词:

摘要: Background: One of the major adverse effects long term cyclosporine A (CyA) administration is chronic nephrotoxicity. Several studies have suggested that alterations L-arginine (L-Arg) nitric oxide (NO) pathway may be involved in pathogenesis CyA-induced kidney damage. Aim: We postulated vivo activation L-Arg-NO might a beneficial effect on renal Conditions NO enhancement was established with L-Arg supplementation and blockade N-nitro-L-Arg methyl ester (L-NAME). tested hypothesis that, if CyA alters intrarenal synthesis, then exogenous could limit injury, contrary, L-NAME, potent competitive inhibitor enhance Harmful indirectly supports model Methods: Rats were administered vehicle (VH), (7.5 mg/kg/day), + (2g/kg/day), L-NAME (5 mg/100 ml/day), VH L-Arg, sacrificed at end experiment. Body weight, serum creatinine, blood urea nitrogen (BUN) levels determined. Tubular injury interstitial fibrosis evaluated semiquantitatively using scoring systems paraffin sections stained hematoxylin/eosin (H/E), Masson’s trichromic periodic acid-Schiff (PAS). Results: The group developed marked characterized by significant increase creatinine BUN, histopathological including tubular dilatation, vacuolization, necrosis, cell infiltration tubulointerstitial fibrosis. reduced level. treatment significantly enhanced biosynthesis protected animals from In contrast strikingly level, worsened biochemical alterations. Conclusion: Chronic nephrotoxicity can aggravated ameliorated suggesting protective

参考文章(30)
P Vallance, J Collier, Biology and clinical relevance of nitric oxide. BMJ. ,vol. 309, pp. 453- 457 ,(1994) , 10.1136/BMJ.309.6952.453
Michael Somogyi, A METHOD FOR THE PREPARATION OF BLOOD FILTRATES FOR THE DETERMINATION OF SUGAR Journal of Biological Chemistry. ,vol. 86, pp. 655- 663 ,(1930) , 10.1016/S0021-9258(20)78933-7
Syed O. Huq, Michael J. Field, Fiona J. Johnson, David W. Johnson, Carol A. Pollock, Heather J. Saunders, Cyclosporin Exerts a Direct Fibrogenic Effect on Human Tubulointerstitial Cells: Roles of Insulin-Like Growth Factor I, Transforming Growth Factor β1, and Platelet-Derived Growth Factor Journal of Pharmacology and Experimental Therapeutics. ,vol. 289, pp. 535- 542 ,(1999)
Wei-Zhong Ying, Paul W. Sanders, Dietary salt enhances glomerular endothelial nitric oxide synthase through TGF-β1 American Journal of Physiology-renal Physiology. ,vol. 275, ,(1998) , 10.1152/AJPRENAL.1998.275.1.F18
Ciro Esposito, Alessia Fornoni, Flavia Cornacchia, Nicoletta Bellotti, Gianluca Fasoli, Annalisa Foschi, Iolanda Mazzucchelli, Tiziana Mazzullo, Luca Semeraro, Antonio Dal Canton, None, Cyclosporine induces different responses in human epithelial, endothelial and fibroblast cell cultures. Kidney International. ,vol. 58, pp. 123- 130 ,(2000) , 10.1046/J.1523-1755.2000.00147.X
William M. Bennett, Angelo DeMattos, Mary M. Meyer, Takeshi Andoh, John M. Barry, Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy Kidney International. ,vol. 50, pp. 1089- 1100 ,(1996) , 10.1038/KI.1996.415
Bruce C. Kone, Nitric oxide in renal health and disease American Journal of Kidney Diseases. ,vol. 30, pp. 311- 333 ,(1997) , 10.1016/S0272-6386(97)90275-4
Michael P. Gardner, Donald C. Houghton, Takeshi F. Andoh, Jessie Lindsley, William M. Bennett, Clinically relevant doses and blood levels produce experimental cyclosporine nephrotoxicity when combined with nitric oxide inhibition. Transplantation. ,vol. 61, pp. 1506- 1512 ,(1996) , 10.1097/00007890-199605270-00017
Fuad S. Shihab, William M. Bennett, Amie M. Tanner, Takeshi F. Andoh, Angiotensin II blockade decreases TGF-β1 and matrix proteins in cyclosporine nephropathy Kidney International. ,vol. 52, pp. 660- 673 ,(1997) , 10.1038/KI.1997.380
Takeshi F. Andoh, Michael P. Gardner, William M. Bennett, Protective effects of dietary L-arginine supplementation on chronic cyclosporine nephrotoxicity Transplantation. ,vol. 64, pp. 1236- 1240 ,(1997) , 10.1097/00007890-199711150-00002